Observational studyMedicine2025
Association between uric acid to albumin ratio and all-cause mortality among United States adults: An observational study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Diagnostic Performance of the Uric Acid-To-Albumin Ratio in Predicting Severity of Acute Pancreatitis.JGH open : an open access journal of gastroenterology and hepatology · 2026Article
- Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.Journal of clinical medicine · 2026Article
- Association of the uric acid to albumin ratio with early glycemic disturbances beyond conventional OGTT criteria.BMC endocrine disorders · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study aimed to investigate if the ratio of uric acid to albumin (UAR) correlates with all-cause mortality. Smooth curve fitting was employed to analyze the association between UAR and all-cause mortality; a threshold saturation effect model was utilized to identify the inflection point of UAR's impact on all-cause mortality. Furthermore, the association between UAR and all-cause mortality from heart disease was assessed using a competing risks model. This study included 25,437 male participants and 27,090 female participants. Smooth curves fitting revealed a U-shaped relationship, demonstrating a distinct inflection point for UAR and all-cause mortality, with the inflection point for females appearing earlier than for males. Kaplan-Meier curves indicated a significantly elevated risk of death in the high UAR group (1.49 < UAR < 4.65) compared to the low UAR group (0 < UAR < 1.03). UAR emerges as a robust independent prognostic indicator for all-cause mortality and could serve as a readily accessible and valuable novel inflammatory marker for identifying high-risk patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.